Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
D. Santos Ribeiro (Brussels, Belgium), M. Lecocq (Brussels, Belgium), M. De Beukelaer (Brussels, Belgium), C. Bouzin (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), R. Quarck (Leuven, Belgium), O. Vancaenegem (Brussels, Belgium), F. Huaux (Brussels, Belgium), S. Horman (Brussels, Belgium), F. Perros (Paris, France), L. Godinas (Leuven, Belgium), C. Pilette (Brussels, Belgium)
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Santos Ribeiro (Brussels, Belgium), M. Lecocq (Brussels, Belgium), M. De Beukelaer (Brussels, Belgium), C. Bouzin (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), R. Quarck (Leuven, Belgium), O. Vancaenegem (Brussels, Belgium), F. Huaux (Brussels, Belgium), S. Horman (Brussels, Belgium), F. Perros (Paris, France), L. Godinas (Leuven, Belgium), C. Pilette (Brussels, Belgium). Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension. 3277
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: